ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia

Leukemia

Volumn 7, Issue 5, 1993, Pages 702-706

  MacKenzie, Elaine ^a   Stewart, Evelyn ^a   Birnie, G D ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CHROMOSOME 9Q; EXON; GENE AMPLIFICATION; GENE FUSION; GENETIC TRANSCRIPTION; HUMAN; LEUKOCYTE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMAN; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; ONCOGENES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION, GENETIC;

EID: 0027251895     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Galton D. The chronic leukaemias. In: Hoffbrand AV, Lewis SM, eds. Postgraduate haematology, 2nd edition. London: Heinemann Medical Books, 1981, pp 478-512.
2. Rowley JD, Testa JR. Chromosome abnormalities in malignant hematologic diseases. Adv Cancer Res 1982; 36:103-148.
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984;36:93-99.
4. Bernards A, Rubin CM, Westbrook CA, Paskind M, Baltimore D. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol 1987; 7:3231-3236.
5. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 1986;47: 277-284.
6. McWhirter JR, Wang JYJ. Activation of tyrosine kinase and microfilament - binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 1991;11:1553-1565.
7. Daley GQ, Ben-Neriah Y. Implicating the bcr/abl gene in the pathogenesis of Philadelphia-chromosome-positive human leukemia. Adv Cancer Res 1991;57:151-184.
8. Daley GQ, van Etten RA, Baltimore D. Blast crisis in a murine model of chronic myelogenous leukemia. Proc Natl Acad Sci USA 1991;88:11335-11338.
9. Reik W. Imprinting in leukaemia. Nature 1992;359: 362-363.
10. Haas OA, Argyriou-Tirita A, Lion T. Parental origin of chromosomes involved in the translocation t(9;22). Nature 1992;359:414-416.
11. Westbrook CA, Rubin CM, Carrino JJ, Le Beau MM, Bernards A, Rowley JD. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. Blood 1988;71:697-702.
12. Nishigaki H, Misawa S, Inazawa J, Abe T. Absence in Ph-negative, M-bcr rearrangement positive chronic myelogenous leukemia of linkage between 5′ abl and 3′ bcr sequences in Philadelphia translocation. Leukemia 1992;6:385-392.
13. Yamada T, Seeker-Walker LM. Possible evidence for acquired genetic activity at both chromosomal break points of the Philadelphia translocation in chronic myeloid leukemia. Leukemia 1990;4:341-344.
14. Hermans A, Gow J, Selleri L, von Lindern M, Hagemeijer A, Wiedemann LM, Grosveld G. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1988;2:628-633.
15. Mills KI, Hynds SA, Burnett AK, MacKenzie ED, Birnie GD. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator. Leukemia 1989;3:837-840.
16. Hultman T, Bergh S, Moks T, Uhlen M. Bidirectional solid phase sequencing of in vitro amplified plasmid DNA. Biotechniques 1991;10:84-93.
17. Fainstein E, Einat M, Gokkel E, Marcelle C, Groce CM, Gale RP, Canaani E. Nucleotide sequence analysis of human abl and bcr-abl cDNAs. Oncogene 1989;4: 1477-1481.
18. 1 translocation. Nature 1985;315:758-761.
19. Selleri L, von Lindern M, Hermans A, Meijer D, Torelli G, Grosveld G. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia - type 7 kb transcript. Blood 1990;75:1146-1153.
20. Mills KI, Benn P, Birnie GD. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991;78:1155-1161.
21. Mills KI, MacKenzie ED, Birnie GD. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. Blood 1988;72: 1237-1241.
22. rac. Nature 1991;351: 400-402.
23. Dhut S, Chaplin T, Young BD. BCR-ABL and BCR proteins: biochemical characterization and localization. Leukemia 1990;4:745-750.
24. Van Etten RA, Jackson P, Baltimore D. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 1989;58:669-678.
25. Dhut S, Chaplin T, Young BD. Normal c-abl gene product - a nuclear component. Oncogene 1991;6: 1459-1464.
26. Jackson P, Baltimore D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 1989;8:449-456.
27. Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D. Alternative 5′ exons in c-abl mRNA. Cell 1986;44:577-586.
28. Henkemeyer M, West SR, Gertier FB, Hoffmann FM. A novel tyrosine kinase - independent function of Drosophila abl correlates with proper subcellular localization. Cell 1990;63:949-960.